A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer

Clinical trial NCT06661122 · RECRUITING

Trial details

NCT number: NCT06661122
Sponsor: Bayer
Status: RECRUITING
Study type: OBSERVATIONAL

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Low-volume Metastasis

Start date: 2024-11-18
Primary completion: 2031-03-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.